+390677209020 | +39 0267380552 info@direnzo.biz | sedemilano@direnzo.biz | Italian Language
Forbidden claims on food supplements

Use of forbidden claims on food supplements

The use of food supplements in Italy is increasingly widespread, but at the same time the presence on the market...

Di Renzo Regulatory Affairs is part of Unindustria

Di Renzo Regulatory Affairs has become a member of Unindustria, a regional association that is part of the system of...

Regulatory Affairs Today

What are the Regulatory Affairs today?

It is a lesson from great masters that the more you know a subject the easier you will be able...

What are orphan drugs?

What are orphan drugs?

What are orphan drugs? Why are they important? Is there any incentive for their development? Orphan drugs are medicines developed...

Quality Management System

Quality Management System for medical devices/in vitro diagnostics (DM/IVD)

The Quality Management System (QMS) is a control system, i.e. a set of activities aimed at verifying that the outcomes...

Artificial Intelligence in medical devices

Artificial Intelligence in medical devices: challenges and opportunities

The sector of Artificial Intelligence (AI) is continuously evolving, and in the next few years the impact of this new...

Sworn translations

Sworn translations. How, where, when

In an increasingly globalised world – where transactions, performances and services mostly occur at international level – sworn translations have...

Food for Special Medical Purposes

Food for Special Medical Purposes

Food for Special Medical Purposes (FSMP) is a very particular category of products, for people with specific food/nutritional difficulties. From...

Serialisation and traceability

Serialisation and traceability, the fight against counterfeiting continues

On 9 February 2019 Directive 2011/62/EU of the European Parliament and of the Council amending Directive 2001/83/EC, on the Community...

Herbals in medical devices

Herbals in medical devices: how to manage your products with MDCG 2022-5

In April 2022, the awaited guideline on borderline devices was published pursuant to Regulation 2017/745. The document MDCG 2022-5, “Guidance...